Home Latest Filings Latest Buys Latest Sells Institutions Derivatives Hot Buys Data Screener Email Alerts Insider Charts
XENE - As of  04/30/25, 12:12:48 PM:   40 Insider Transactions.

Sector: Unknown    Industry: Unknown
Prev Close:$8.13  Avg Vol(3m): 18,173  P/E: 0.00  EPS: -0.69

Email this page to a friend.    Insider Transactions for XENE

Buy/Sell* Filed Date Subject Symbol Acquirer Pct Owned Details
B 2020-06-22 17:17:24.0 Xenon Pharmaceuticals Inc XENE BIOTECHNOLOGY VALUE FUND L P 10.1% view
B 2020-02-14 15:29:42.0 Xenon Pharmaceuticals Inc XENE BIOTECHNOLOGY VALUE FUND L P 9.99% view
S 2020-02-13 16:30:27.0 Xenon Pharmaceuticals Inc XENE Vivo Opportunity 2.9% view
B 2020-02-12 16:16:54.0 Xenon Pharmaceuticals Inc XENE ADAGE CAPITAL PARTNERS GP 7.44% view
B 2019-12-11 16:14:14.0 Xenon Pharmaceuticals Inc XENE NEUROCRINE BIOSCIENCES INC 5.4% view
B 2019-02-14 16:19:24.0 Xenon Pharmaceuticals Inc XENE BIOTECHNOLOGY VALUE FUND L P 9.99% view
B 2019-02-14 15:39:53.0 Xenon Pharmaceuticals Inc XENE Vivo Opportunity 5.6% view
B 2019-02-14 08:37:02.0 Xenon Pharmaceuticals Inc XENE venBio Select Advisor LLC 9.5% view
B 2019-02-13 18:33:41.0 Xenon Pharmaceuticals Inc XENE SMALLCAP WORLD FUND INC 7.5% view
S 2019-02-13 14:09:47.0 Xenon Pharmaceuticals Inc XENE ADAGE CAPITAL PARTNERS GP 5.15% view
S 2018-08-10 13:01:24.0 Xenon Pharmaceuticals Inc XENE Capital World Investors 3.2% view
B 2018-07-13 13:59:26.0 Xenon Pharmaceuticals Inc XENE Vivo Opportunity 5.6% view
B 2018-07-03 12:56:55.0 Xenon Pharmaceuticals Inc XENE ADAGE CAPITAL PARTNERS GP 5.64% view
B 2018-06-08 13:33:40.0 Xenon Pharmaceuticals Inc XENE Capital World Investors 10.0% view
S 2018-03-29 17:12:48.0 Xenon Pharmaceuticals Inc XENE BIOTECHNOLOGY VALUE FUND L P 9.99% view
B 2018-02-14 14:28:23.0 Xenon Pharmaceuticals Inc XENE BIOTECHNOLOGY VALUE FUND L P 19.9% view
B 2018-02-13 17:35:10.0 Xenon Pharmaceuticals Inc XENE Capital World Investors 7.9% view
B 2018-02-13 16:49:53.0 Xenon Pharmaceuticals Inc XENE ORBIMED ADVISORS LLC 3.55% view
S 2017-02-14 12:47:32.0 Xenon Pharmaceuticals Inc XENE BIOTECHNOLOGY VALUE FUND L P 17.0% view
S 2017-02-14 12:28:57.0 Xenon Pharmaceuticals Inc XENE INTERWEST PARTNERS VII L P 1.8% view
S 2017-02-14 12:11:55.0 Xenon Pharmaceuticals Inc XENE FMR LLC n/a view
S 2017-02-13 17:04:56.0 Xenon Pharmaceuticals Inc XENE Capital World Investors 6.8% view
B 2017-02-13 14:27:18.0 Xenon Pharmaceuticals Inc XENE OrbiMed Capital GP VI LLC 5.59% view
S 2017-02-13 09:21:03.0 Xenon Pharmaceuticals Inc XENE Troendle August J 2.34% view
S 2017-02-13 09:17:32.0 Xenon Pharmaceuticals Inc XENE STEIN EVAN A 2.48% view
B 2016-09-12 08:58:45.0 Xenon Pharmaceuticals Inc XENE BIOTECHNOLOGY VALUE FUND L P 17.9% view
B 2016-03-29 17:31:16.0 Xenon Pharmaceuticals Inc XENE TEVA PHARMACEUTICAL INDUSTRIES LTD 7.7% view
B 2016-03-18 17:15:30.0 Xenon Pharmaceuticals Inc XENE BIOTECHNOLOGY VALUE FUND L P 12.3% view
S 2016-02-26 14:31:01.0 Xenon Pharmaceuticals Inc XENE Troendle August J 7.49% view
B 2016-02-12 17:33:20.0 Xenon Pharmaceuticals Inc XENE Capital World Investors 7.2% view
S 2016-02-12 15:50:36.0 Xenon Pharmaceuticals Inc XENE STEIN EVAN A 6.43% view
S 2016-02-12 09:33:10.0 Xenon Pharmaceuticals Inc XENE FMR LLC 6.405% view
S 2016-02-12 06:10:31.0 Xenon Pharmaceuticals Inc XENE INTERWEST PARTNERS VII L P 5.6% view
B 2015-07-10 16:40:32.0 Xenon Pharmaceuticals Inc n/a BIOTECHNOLOGY VALUE FUND L P 5.8% view
B 2015-02-17 14:25:34.0 Xenon Pharmaceuticals Inc n/a STEIN EVAN A 7.41% view
S 2015-02-13 18:40:29.0 Xenon Pharmaceuticals Inc n/a BIOTECHNOLOGY VALUE FUND L P 4.4% view
B 2015-02-13 10:41:41.0 Xenon Pharmaceuticals Inc n/a FMR LLC 9.278% view
B 2015-02-13 06:17:35.0 Xenon Pharmaceuticals Inc n/a INTERWEST PARTNERS VII L P 5.7% view
B 2015-01-12 16:20:35.0 Xenon Pharmaceuticals Inc n/a Troendle August J 8.26% view
B 2014-11-14 16:23:57.0 Xenon Pharmaceuticals Inc n/a BIOTECHNOLOGY VALUE FUND L P 5.2% view
* Institutions do not report transaction buy/sell types directly. To help members better understand the transactions, this column is filled by InsiderCow's best-effort interpretations.